Cargando…
Evaluation of SARS-CoV-2 viral RNA in fecal samples
The need for timely establishment of a complete diagnostic protocol of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is demanded worldwide. We selected 15 positive novel coronavirus disease 19 (COVID-19) patients with mild or no symptom. Initially, fecal samples were negative in the 6...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324771/ https://www.ncbi.nlm.nih.gov/pubmed/32605577 http://dx.doi.org/10.1186/s12985-020-01359-1 |
_version_ | 1783552014087618560 |
---|---|
author | Mesoraca, Alvaro Margiotti, Katia Viola, Antonella Cima, Antonella Sparacino, Davide Giorlandino, Claudio |
author_facet | Mesoraca, Alvaro Margiotti, Katia Viola, Antonella Cima, Antonella Sparacino, Davide Giorlandino, Claudio |
author_sort | Mesoraca, Alvaro |
collection | PubMed |
description | The need for timely establishment of a complete diagnostic protocol of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is demanded worldwide. We selected 15 positive novel coronavirus disease 19 (COVID-19) patients with mild or no symptom. Initially, fecal samples were negative in the 67% (10/15) of the cases, while 33% (5/10) of the cases were positive. After serial virus RNA testing, 73% (11/15) of the cases resulted positive to fecal specimens. In particular, 15 days after the first positive respiratory specimens test, 6 fecal specimens became positive for SARS-CoV-2 RNA, while 13 respiratory test returned negative result. In conclusion, qRT-PCR assays of fecal specimens, is an important step to control infection, suggesting that samples remained positive for SARS-CoV-2 RNA longer time then respiratory tract samples. Our results enhance the recent knowledge on this emerging infectious disease and offer suggestions for a more complete diagnostic strategy. |
format | Online Article Text |
id | pubmed-7324771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73247712020-06-30 Evaluation of SARS-CoV-2 viral RNA in fecal samples Mesoraca, Alvaro Margiotti, Katia Viola, Antonella Cima, Antonella Sparacino, Davide Giorlandino, Claudio Virol J Short Report The need for timely establishment of a complete diagnostic protocol of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is demanded worldwide. We selected 15 positive novel coronavirus disease 19 (COVID-19) patients with mild or no symptom. Initially, fecal samples were negative in the 67% (10/15) of the cases, while 33% (5/10) of the cases were positive. After serial virus RNA testing, 73% (11/15) of the cases resulted positive to fecal specimens. In particular, 15 days after the first positive respiratory specimens test, 6 fecal specimens became positive for SARS-CoV-2 RNA, while 13 respiratory test returned negative result. In conclusion, qRT-PCR assays of fecal specimens, is an important step to control infection, suggesting that samples remained positive for SARS-CoV-2 RNA longer time then respiratory tract samples. Our results enhance the recent knowledge on this emerging infectious disease and offer suggestions for a more complete diagnostic strategy. BioMed Central 2020-06-30 /pmc/articles/PMC7324771/ /pubmed/32605577 http://dx.doi.org/10.1186/s12985-020-01359-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Short Report Mesoraca, Alvaro Margiotti, Katia Viola, Antonella Cima, Antonella Sparacino, Davide Giorlandino, Claudio Evaluation of SARS-CoV-2 viral RNA in fecal samples |
title | Evaluation of SARS-CoV-2 viral RNA in fecal samples |
title_full | Evaluation of SARS-CoV-2 viral RNA in fecal samples |
title_fullStr | Evaluation of SARS-CoV-2 viral RNA in fecal samples |
title_full_unstemmed | Evaluation of SARS-CoV-2 viral RNA in fecal samples |
title_short | Evaluation of SARS-CoV-2 viral RNA in fecal samples |
title_sort | evaluation of sars-cov-2 viral rna in fecal samples |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324771/ https://www.ncbi.nlm.nih.gov/pubmed/32605577 http://dx.doi.org/10.1186/s12985-020-01359-1 |
work_keys_str_mv | AT mesoracaalvaro evaluationofsarscov2viralrnainfecalsamples AT margiottikatia evaluationofsarscov2viralrnainfecalsamples AT violaantonella evaluationofsarscov2viralrnainfecalsamples AT cimaantonella evaluationofsarscov2viralrnainfecalsamples AT sparacinodavide evaluationofsarscov2viralrnainfecalsamples AT giorlandinoclaudio evaluationofsarscov2viralrnainfecalsamples |